View Full Profile. Learn about our Editorial Policies. Towards the final stages of diseases such as cancer and kidney disease, many patients develop cachexia, a devastating condition in which muscle ...

The experimental drug ponsegromab is a monoclonal antibody that treats the growth factor that leads to the growth of cancer ...

Cachexia is a serious yet under-recognized consequence of many chronic diseases, including heart disease, kidney disease, chronic obstructive pulmonary disease and, most notably, cancer.

Cardiac cachexia is the weight loss and decrease in appetite that occurs during states of chronically low cardiac output and congestive heart failure. This gives a poor prognosis independent of ...

View Full Profile. Learn about our Editorial Policies. Cancer cachexia, or the wasting syndrome, is a catastrophic condition that causes dramatic and involuntary loss of muscle mass, fat and weight, ...

Historically, cachexia has not been fully understood. Also known as wasting syndrome, cachexia is often incorrectly viewed as simply an inevitable side effect to cancer and other chronic conditions.

The work is published in the Journal of Cachexia, Sarcopenia and Muscle. "We are the first to study how certain drugs affect bones, and the results show that bimagrumab can increase the amount of ...

Considering taking supplements to treat cachexia? Below is a list of common natural remedies used to treat or reduce the symptoms of cachexia. Follow the links to read common uses, side effects ...

Screening and Referral for Health-Related Social Needs and Financial Distress: Current Processes Among National Cancer Institute Community Oncology Research Program Practices Cancer-associated ...

Publication of SARA-INT Phase II results for BIO101Confirmation of Phase 3 readinessParis, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis ...

A new study has found over sixty per cent of women undergoing Cervical Cancer treatment at the Uganda Cancer Institute (UCI) ...

Artificial Intelligence in Oncology: Fulfilling Its Promise While Avoiding Its Peril We would like to thank Drs Molfino and Imbimbo 1 for their thoughtful response to our Call to Improve Coding of ...